Is tumour vaccination a valid alternative to second line treatment in hormone refractory prostate cancer? A review of the evidence

Onderzoeksoutput: Articlepeer review

Originele taal-2English
Pagina's (van-tot)1-6
Aantal pagina's6
TijdschriftUroOncology
Volume3
StatusPublished - 2003

Citeer dit